dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Fernandes Neto, João M. |
dc.contributor.author | Bosdriesz, Evert |
dc.contributor.author | Ooft, Salo N. |
dc.contributor.author | Farre, Lourdes |
dc.contributor.author | McLean, Chelsea |
dc.contributor.author | Felip Font, Enriqueta |
dc.contributor.author | Martínez Marti, Alexandre |
dc.contributor.author | Nadal, Ernest |
dc.date.accessioned | 2021-09-02T09:24:12Z |
dc.date.available | 2021-09-02T09:24:12Z |
dc.date.issued | 2020-06-22 |
dc.identifier.citation | Fernandes Neto JM, Nadal E, Bosdriesz E, Ooft SN, Farre L, McLean C, et al. Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours. Nat Commun. 2020 Jun 22;11:3157. |
dc.identifier.issn | 2041-1723 |
dc.identifier.uri | https://hdl.handle.net/11351/6257 |
dc.description | Càncer; Càncer de pulmó; Farmacoresistència |
dc.description.sponsorship | This work was supported by a grant from the Dutch Cancer Society through the Oncode Institute. Al.V. was supported by the Fondo de Investigaciones Sanitarias, FIS (PI16-01898, and by the Spanish Association Against Cancer, AECC (CGB14142035THOM) and Ideas Semilla project (IDEAS098VILL-IDEAS16) and Generalitat de Catalunya (2014SGR364). L.F. received a European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie, grant agreement number 799850. E.N. was funded by Instituto Carlos III through the project PI18/00920. We thank CERCA Program/Generalitat de Catalunya for their institutional support and grant 2017SGR448. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Nature Communications;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Tumors |
dc.subject | Resistència als medicaments |
dc.subject.mesh | Carcinoma, Non-Small-Cell Lung |
dc.subject.mesh | Drug Resistance, Neoplasm |
dc.title | Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41467-020-16952-9 |
dc.subject.decs | carcinoma de pulmón de células no pequeñas |
dc.subject.decs | resistencia a los antineoplásicos |
dc.relation.publishversion | https://doi.org/10.1038/s41467-020-16952-9 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Fernandes Neto JM] Division of Molecular Carcinogenesis and Oncode Institute. The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. [Nadal E] Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer Therapeutic Resistance (ProCURE), ICO, Oncobell Program, IDIBELL, L’Hospitalet del Llobregat, Barcelona, Spain. [Bosdriesz E] Division of Molecular Carcinogenesis and Oncode Institute. The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Department of Computer Science, Faculty of Science, Vrije Universiteit, Amsterdam, The Netherlands. [Ooft SN, McLean C] Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. [Farre L] Group of Chemoresistance and Predictive Factors, Subprogram Against Cancer Therapeutic Resistance (ProCURE), ICO, Oncobell Program, IDIBELL, L’Hospitalet del Llobregat, Barcelona, Spain. Institute Gonçalo Moniz, Fundaçao Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, Brasil. [Felip E, Martinez-Marti A] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 32572029 |
dc.identifier.wos | 000544742300004 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI16%2F01898 |
dc.relation.projectid | info:eu-repo/grantAgreement/EC/H2020/799850 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00920 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2014SGR364 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR448 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |